InMed Pharmaceuticals
14 hedge funds and large institutions have $342K invested in InMed Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$64.5K | |
| 2 | +$18.9K | |
| 3 | +$14.7K | |
| 4 |
Millennium Management
New York
|
+$14.7K |
| 5 |
Renaissance Technologies
New York
|
+$1.05K |